new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Agios Pharmaceuticals Inc patents

Recent patent applications related to Agios Pharmaceuticals Inc. Agios Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Agios Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Agios Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Agios Pharmaceuticals Inc-related inventors




Date Agios Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
04/20/17 new patent  Therapeutically active compounds and their methods of use
03/02/17Therapeutically active compounds and their methods of use
02/16/17Therapeutically active compounds and their methods of use
02/16/17Methods and compositions for cell-proliferation-related disorders
02/09/17Therapeutically active compounds and their methods of use
01/19/17Pharmaceutical compositions of therapeutically active compounds
01/19/17Therapeutically active compositions and their methods of use
01/12/17Activators of pyruvate kinase m2 and methods of treating disease
01/12/17Pharmaceutical compositions of therapeutically active compounds
11/03/16Therapeutically active compositions and their methods of use
10/20/16Therapeutically active compounds and their methods of use
09/29/16Therapeutically active compositions and their methods of use
09/15/16Therapeutically active compositions and their methods of use
08/11/16Therapeutically active compositions and their methods of use
08/04/16Therapeutically active compounds and their methods of use
07/07/16Therapeutically active compounds and their methods of use
06/09/162,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
06/09/16N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer
06/09/16Therapeutically active compounds and their methods of use
05/12/16Therapeutically active compositions and their methods of use
04/21/16Pyruvate kinase activators for use in therapy
03/31/16Therapeutically active compounds and their methods of use
02/25/16Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
02/18/16Therapeutic compounds and compositions
11/26/15Therapeutic compounds and compositions
10/29/15Therapeutic compounds and compositions and their use as pkm2 modulators
10/29/15Therapeutic compounds and compositions and their use as pkm2 modulators
10/22/15Therapeutic compounds and compositions
10/22/15Therapeutic compounds and compositions
10/22/15Glutamase inhibitors and use
10/15/15Compounds and their methods of use
10/01/15Use of e-cadherin and vimentin for selection of treatment responsive patients
08/27/15Methods and compositions for cell-proliferation-related disorders
07/02/15Therapeutic compounds and compositions
03/26/15Therapeutically active compounds and their methods of use
01/29/15Therapeutically active compounds and their methods of use
01/15/15Therapeutically active compounds and their methods of use
10/30/14Therapeutic compounds and compositions
10/30/14Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
09/25/14Therapeutic compounds and compositions
09/04/14Activators of pyruvate kinase m2 and methods of treating disease
07/31/14Therapeutically active compositions and their methods of use
07/24/14Therapeutically active compositions and their methods of use
07/10/14Pyruvate kinase activators for use in therapy
07/03/14Methods and compositions for cell-proliferation-related disorders
06/26/14Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
06/05/14Methods of using pyruvate kinase activators
06/05/14Pyruvate kinase activators for use in therapy
05/29/14Methods of using pyruvate kinase activators
05/22/14Compounds and their methods of use
05/22/14Compounds and their methods of use
03/13/14Novel n-(4-(azetidine-1-carbonyl) phenyl) - (hetero-) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
01/09/14Bicyclic pkm2 activators
08/01/13Methods of identifying a candidate compound
07/25/13Therapeutically active compositions and their methods of use
07/25/13Therapeutically active compounds and their methods of use
07/18/13Therapeutically active compositions and their methods of use







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Agios Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Agios Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';